(2S,4R)-pyrrolidine-2,4-dicarboxylic acid
-
(2S,4R)-pyrrolidine-2,4-dicarboxylic acid
structure -
-
CAS No:
64769-66-0
-
Formula:
C6H9NO4
-
Chemical Name:
(2S,4R)-pyrrolidine-2,4-dicarboxylic acid
-
Synonyms:
1-pyrrolidine-2,4-dicarboxylic acid;1-trans-pyrrolidine-2,4-dicarboxylic acid;2,4-pyrrolidine dicarboxylate;L-pyrrolidine-2,4-dicarboxylic acid;L-trans-2,4-pyrrolidine dicarboxylate;L-trans-pyrrolidine-2,4-dicarboxylic acid;PDC-2,4;pyrrolidine-2,4-dicarboxylate;pyrrolidine-2,4-dicarboxylic acid;pyrrolidine-2,4-dicarboxylic acid, (2R-cis)-isomer;pyrrolidine-2,4-dicarboxylic acid, (2R-trans)-isomer;pyrrolidine-2,4-dicarboxylic acid, (2S-cis)-isomer;pyrrolidine-2,4-dicarboxylic acid, (2S-trans)-isomer;64769-66-0;trans-4-Carboxy-L-proline;L-trans-2,4-PDC;(2S,4R)-Pyrrolidine-2,4-dicarboxylic acid;L-trans-Pyrrolidine-2,4-dicarboxylic acid;t-PDC;Tocris-0298;2,4-Pyrrolidinedicarboxylic acid, (2S,4R)-;L-trans-4-Carboxy-L-proline;t-2,4-PDC;CHEMBL349384;SCHEMBL1133665;BDBM85211;DTXSID50363910;ZINC3796127;MFCD00153866;PDSP1_000261;PDSP2_000260;AKOS006275185;NCGC00024527-01;2,4-Pyrrolidinedicarboxylicacid,(2S,4R)-;B6250;SR-01000597627;L-trans-Pyrrolidine-2,4-dicarboxylic acid, >=98%;SR-01000597627-1;(3R,4R)-4-(tert-butoxycarbonylamino)-3-hydroxyoctanoic acid;(3S,4R)-4-(tert-butoxycarbonylamino)-3-hydroxyoctanoic acid
-
CAS No:
(2S,4R)-pyrrolidine-2,4-dicarboxylic acid Basic Attributes
159.14 g/mol
159.05315777 g/mol
DTXSID50363910
Safety Information
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (See all compounds classified as Neurotransmitter Uptake Inhibitors.)
1-pyrrolidine-2,4-dicarboxylic acid
Computed Properties
Molecular Weight:159.14
XLogP3:-3.2
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:2
Exact Mass:159.05315777
Monoisotopic Mass:159.05315777
Topological Polar Surface Area:86.6
Heavy Atom Count:11
Complexity:191
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
3,5-DIBROMO-2-[[[(3,5-DINITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
535965-38-9
-
3,5-DIBROMO-2-[[[[(2-CHLOROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532386-89-3
-
3,5-DIBROMO-2-[[[(4-METHYL-3-NITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532943-48-9
-
3,5-DIBROMO-2-[[[[3-(2-FURANYL)-1-OXO-2-PROPENYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
586392-09-8
-
3,5-DIBROMO-2-[[[[(2-METHYLPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
531548-30-8
-
2-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid Formula
333340-54-8
-
3,5-DIBROMO-2-[[[[3-(PHENOXYMETHYL)BENZOYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
586393-79-5
-
3,5-DIBROMO-2-[[[(4-CHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
531530-32-2
-
What is 2-Cyclopentyl-3-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-oxo-4-isoquinolinecarboxylic acid
400073-92-9
-
What is 9-Octadecenoic acid (9Z)-, compd. with N,N-dimethylcyclohexanamine (1:1)
65122-23-8
Request for Quotation